Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 17,000 | 33,000 | 26,000 | 160,000 | 28,000 |
| Gross Profit | 17,000 | 33,000 | 26,000 | 160,000 | 28,000 |
| Operating Expenses | 151,000 | 147,000 | 168,000 | 168,000 | 150,000 |
| Operating Income | -134,000 | -114,000 | -142,000 | -8,000 | -122,000 |
| Interest Expense | 3,000 | 2,000 | 3,000 | 2,000 | 1,000 |
| Other Income | 9,000 | 10,000 | 10,000 | 10,000 | 11,000 |
| Pre-tax Income | -128,000 | -106,000 | -135,000 | 0 | -112,000 |
| Net Income Continuous | -128,000 | -106,000 | -135,000 | N/A | -112,000 |
| Net Income | $-128,000 | $-106,000 | $-135,000 | $N/A | $-112,000 |
| EPS Basic Total Ops | -1.02 | -0.88 | -1.27 | N/A | -1.14 |
| EPS Basic Continuous Ops | -1.02 | -0.88 | -1.27 | N/A | -1.14 |
| EPS Diluted Total Ops | -1.02 | -0.88 | -1.27 | N/A | -1.14 |
| EPS Diluted Continuous Ops | -1.02 | -0.88 | -1.27 | N/A | -1.14 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -0.89 | -1.27 | 0.00 | -1.14 |
| EBITDA(a) | $-135,000 | $-114,000 | $-143,000 | $-9,000 | $-123,000 |